F11R and atherosclerosis: JAM-A ability to control platelet aggregation (12) have triggered particular interest in this molecule in studies of vascular diseases such as atherosclerosis, a cardiovascular disease caused by the development of plaques on artery walls restricting or blocking blood flow to specific organs or regions of the body (31).